Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 15.80%268.31M | 17.70%176.85M | 26.38%87.11M | 22.41%332.58M | 25.86%231.69M | 25.75%150.25M | 22.37%68.93M | 31.88%271.71M | 184.09M | 119.48M |
| Operating revenue | 15.80%268.31M | 17.70%176.85M | 26.38%87.11M | 22.41%332.58M | 25.86%231.69M | 25.75%150.25M | 22.37%68.93M | 31.88%271.71M | --184.09M | --119.48M |
| Total operating cost | 25.61%210.51M | 24.56%134.56M | 29.78%64.46M | 27.32%232.48M | 29.01%167.59M | 108.03M | 49.67M | 31.12%182.59M | 129.91M | |
| Operating cost | 24.16%67.45M | 22.03%45.06M | 17.49%20.75M | 34.73%81M | 30.62%54.33M | --36.92M | --17.67M | 22.05%60.12M | --41.59M | ---- |
| Operating tax surcharges | -16.60%1.74M | -9.55%1.32M | 63.94%955.51K | -22.60%2.82M | -23.50%2.08M | --1.46M | --582.83K | 66.55%3.64M | --2.72M | ---- |
| Operating expense | 32.71%68.57M | 31.55%43.97M | 29.94%19.57M | 22.58%72M | 24.98%51.67M | --33.43M | --15.06M | 35.51%58.74M | --41.34M | ---- |
| Administration expense | -0.25%17.63M | 0.86%11.27M | 52.08%6.76M | 20.49%20.59M | 26.20%17.67M | --11.18M | --4.44M | 20.53%17.09M | --14M | ---- |
| Financial expense | -502.30%-5.1M | -151.12%-5.12M | -23.57%-1.43M | 43.36%-3M | 80.49%-847.52K | ---2.04M | ---1.16M | 17.73%-5.3M | ---4.34M | ---- |
| -Interest expense (Financial expense) | -67.99%68.91K | -67.10%50.01K | -71.82%25.36K | -22.55%260.88K | -34.03%215.23K | --151.99K | --90K | 10.82%336.85K | --326.24K | ---- |
| -Interest Income (Financial expense) | -74.73%-2.44M | -69.46%-1.67M | 36.65%-437.44K | 43.68%-1.84M | 19.91%-1.4M | ---984.55K | ---690.54K | -1,983.58%-3.27M | ---1.74M | ---- |
| Research and development | 41.07%60.23M | 40.52%38.06M | 36.57%17.85M | 22.28%59.06M | 23.41%42.7M | --27.08M | --13.07M | 31.53%48.3M | --34.6M | ---- |
| Credit Impairment Loss | 30.24%-789.02K | 63.30%-233.36K | -33.09%-1.46M | -140.34%-1.95M | -90.65%-1.13M | ---635.83K | ---1.09M | 8.70%-810.91K | ---593.29K | ---- |
| Asset Impairment Loss | -63.13%-1.15M | -31.98%-757.01K | -12.59%-496.66K | 51.53%-803.22K | 50.11%-703.24K | ---573.59K | ---441.14K | -2.26%-1.66M | ---1.41M | ---- |
| Other net revenue | ||||||||||
| Fair value change income | --1.42M | --909.91K | --332.19K | --8.9K | ---- | ---- | ---- | ---- | ---- | ---- |
| Invest income | 43.15%10.27M | 29.20%5.51M | 79.82%2.72M | 87.61%10.23M | 77.58%7.18M | --4.26M | --1.51M | 64.40%5.45M | --4.04M | ---- |
| -Including: Investment income associates | -107.27%-396.27K | -302.19%-969.83K | 61.53%-194.15K | -74.38%102.04K | 15.84%-191.18K | ---241.14K | ---504.73K | -35.51%398.25K | ---227.16K | ---- |
| Asset deal income | --41.49K | ---- | ---- | ---- | ---- | ---- | ---12.11K | --20.17K | --17.54K | ---- |
| Other revenue | -11.69%18.04M | -25.46%10.83M | 5.42%6.47M | -25.91%27.32M | -19.70%20.43M | --14.53M | --6.13M | 147.62%36.88M | --25.44M | ---- |
| Adjusted Items effecting operating profit | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | -4.71%85.63M | -2.10%58.54M | 19.14%30.22M | 4.59%134.91M | 10.03%89.87M | 11.01%59.8M | 48.13%25.36M | 56.41%129M | 81.67M | 53.87M |
| Add:Non operating Income | 309.31%148.24K | 306.98%140.41K | 688.82%15.27K | 65.49%79.62K | 47.85%36.22K | --34.5K | --1.94K | 88.12%48.11K | --24.5K | ---- |
| Less:Non operating expense | -55.44%161.39K | -54.19%156.1K | -99.93%125.64 | 370.27%420.74K | 533.98%362.18K | --340.73K | --189.85K | -62.64%89.47K | --57.13K | ---- |
| Total profit | -4.38%85.62M | -1.63%58.53M | 20.09%30.23M | 4.36%134.57M | 9.68%89.54M | 10.52%59.5M | 46.92%25.17M | 56.77%128.95M | 81.64M | 53.83M |
| Less:Income tax cost | -30.68%6.54M | -31.26%4.52M | 11.40%3.26M | -4.45%14.04M | 0.53%9.44M | --6.58M | --2.92M | 217.97%14.7M | --9.39M | ---- |
| Net profit | -1.28%79.08M | 2.06%54.01M | 21.23%26.97M | 5.49%120.53M | 10.86%80.1M | 11.12%52.92M | 43.44%22.25M | 47.17%114.25M | 72.26M | 47.62M |
| Net profit from continuing operation | -1.28%79.08M | 2.06%54.01M | 21.23%26.97M | 5.49%120.53M | 10.86%80.1M | --52.92M | --22.25M | 47.17%114.25M | --72.26M | ---- |
| Net profit of parent company owners | -1.28%79.08M | 2.06%54.01M | 21.23%26.97M | 5.49%120.53M | 10.86%80.1M | 11.12%52.92M | 43.44%22.25M | 47.17%114.25M | --72.26M | --47.62M |
| Earning per share | ||||||||||
| Basic earning per share | -41.40%0.92 | -38.46%0.64 | -2.27%0.43 | 5.36%2.36 | 10.56%1.57 | --1.04 | --0.44 | -39.13%2.24 | --1.42 | ---- |
| Diluted earning per share | -41.40%0.92 | -38.46%0.64 | -2.27%0.43 | 5.36%2.36 | 10.56%1.57 | --1.04 | --0.44 | -39.13%2.24 | --1.42 | ---- |
| Other composite income | 903.64%513.94K | 1,148.30%815.47K | 140.43%132.73K | -168.44%-168.27K | -175.48%-63.95K | -77.79K | -328.28K | 264.08%245.86K | 84.73K | |
| Other composite income of parent company owners | 903.64%513.94K | 1,148.30%815.47K | 140.43%132.73K | -168.44%-168.27K | -175.48%-63.95K | ---77.79K | ---328.28K | 264.08%245.86K | --84.73K | ---- |
| Total composite income | -0.56%79.59M | 3.75%54.82M | 23.65%27.11M | 5.12%120.36M | 10.64%80.04M | 52.84M | 21.92M | 47.36%114.5M | 72.34M | |
| Total composite income of parent company owners | -0.56%79.59M | 3.75%54.82M | 23.65%27.11M | 5.12%120.36M | 10.64%80.04M | --52.84M | --21.92M | 47.36%114.5M | --72.34M | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.